🇧🇪 Belgium Country × Condition
peritoneal carcinomatosis Clinical Trials in Belgium
Active clinical trials for peritoneal carcinomatosis with research sites in Belgium. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇧🇪 Belgium
Active Trials in Belgium (2)
NCT06504147 Phase 2
Recruiting
A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
Enrollment
114 pts
Country
🇧🇪 Belgium
Oncoinvent Solutions AS
View Trial → NCT01617382
Recruiting
Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed
Enrollment
125 pts
Country
🇧🇪 Belgium
Universitaire Ziekenhuizen KU Leuve...
View Trial → Frequently Asked Questions
How many peritoneal carcinomatosis clinical trials are active in Belgium?
There are currently 2 active clinical trials for peritoneal carcinomatosis with sites in Belgium, of which 2 are actively recruiting patients.
How can I join a peritoneal carcinomatosis clinical trial in Belgium?
To join a peritoneal carcinomatosis clinical trial in Belgium, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Belgium directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are peritoneal carcinomatosis trials in Belgium?
Active peritoneal carcinomatosis trials in Belgium span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology